GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Alcohol is responsible for a significant portion of global disease and death, contributing to 2.6 million deaths annually. It ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

President Trump held a phone call today with Vladimir Putin that he described as “lengthy and highly productive.” He ...

Semaglutide (Wegovy) may help heavy drinkers cut down on their alcohol intake in addition to losing weight, a trial has found ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...